| Line Item | 2026-02-28 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $206.7M | -5.0% | +11.3% |
| Cost of Revenue | $151.8M | -5.1% | +13.5% |
| Gross Profit | $55.0M | -4.4% | +5.7% |
| R&D Expense | $62K | -20.5% | -27.1% |
| SG&A Expense | $50.2M | -1.9% | +28.0% |
| Operating Income | -$26.4M | -18.4% | +96.5% |
| Pre-tax Income | -$23.3M | +41.8% | +97.1% |
| Income Tax | $2.0M | -44.3% | +64.1% |
| Net Income | -$26.6M | +40.9% | +96.6% |
| EPS (Basic) | -$0.24 | +41.5% | +72.4% |
| EPS (Diluted) | -$0.24 | +41.5% | +72.4% |
| Line Item | 2026-02-28 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $204.6M | -17.1% | — |
| Short-term Investments | $15.3M | -65.9% | — |
| Accounts Receivable | $118.4M | +8.5% | — |
| Inventory | $292.3M | +3.2% | +11.0% |
| Current Assets | $718.8M | -1.4% | — |
| Total Assets | $2.07B | -1.1% |
| Line Item | 2026-02-28 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$31.8M | — | — |
| Investing Cash Flow | -$4.6M | — | — |
| Financing Cash Flow | $62.8M | — | — |
| — |
| Current Liabilities | $257.5M | -0.7% | — |
| Total Liabilities | $549.1M | -0.5% | — |
| Stockholders' Equity | $1.56B | -1.4% | -42.4% |